<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2017 (12) TMI 570 - ITAT BANGALORE</title>
    <link>https://www.taxtmi.com/caselaws?id=352301</link>
    <description>The commentary addresses multiple income-tax issues, including deductibility of provision for interest to Customs, interest on delayed payment to MSMEs, taxation of sub-licensing receipts, eligibility for deduction under section 80JJAA, computation of weighted deduction under section 35(2AB), disallowance under section 14A read with Rule 8D, and classification of software and trademark-related expenditure. It states that delayed-payment MSME interest is barred by the MSMED Act and that sub-licensing of non-exclusive technology rights does not amount to transfer of a capital asset. It also notes that revenue income of an approved R&amp;D centre should not be netted off against eligible section 35(2AB) expenditure, and that section 14A disallowance must rest on actual nexus with exempt income and the relevant funds position.</description>
    <language>en-us</language>
    <pubDate>Mon, 06 Nov 2017 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 08 Aug 2022 15:32:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=499406" rel="self" type="application/rss+xml"/>
    <item>
      <title>2017 (12) TMI 570 - ITAT BANGALORE</title>
      <link>https://www.taxtmi.com/caselaws?id=352301</link>
      <description>The commentary addresses multiple income-tax issues, including deductibility of provision for interest to Customs, interest on delayed payment to MSMEs, taxation of sub-licensing receipts, eligibility for deduction under section 80JJAA, computation of weighted deduction under section 35(2AB), disallowance under section 14A read with Rule 8D, and classification of software and trademark-related expenditure. It states that delayed-payment MSME interest is barred by the MSMED Act and that sub-licensing of non-exclusive technology rights does not amount to transfer of a capital asset. It also notes that revenue income of an approved R&amp;D centre should not be netted off against eligible section 35(2AB) expenditure, and that section 14A disallowance must rest on actual nexus with exempt income and the relevant funds position.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Mon, 06 Nov 2017 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=352301</guid>
    </item>
  </channel>
</rss>